Jak y herpes

Patients With IBD And Other Immune-Mediated Diseases Who Receive JAK Inhibitors May Be At Greater Risk For Herpes Zoster Infection, Review Study Indicates

Healio (1/15, Young) reports, "Patients with inflammatory bowel disease [IBD] and other immune-mediated diseases who receive Janus kinase [JAK] inhibitors may be at increased risk for herpes zoster infection," researchers concluded after studying data from "82 studies comprising 66,159 patients." The findings of the meta-analysis were published online in Gastroenterology.

Sent from my iPhone

Benjamin Hidalgo-Matlock
Skin Care Physicians of Costa Rica

Clinica Victoria en San Pedro: 4000-1054
Momentum Escazu: 2101-9574

Please excuse the shortness of this message, as it has been sent from
a mobile device.